11β-羟化酶缺陷症的临床与激素特征与分子特征相关
该多中心儿童队列回顾性分析了102例11β-羟化酶缺陷症(11βOHD)患者,其中经典型92例、非经典型10例,均携带CYP11B1双等位基因突变。非经典型临床表现较轻,无外生殖器模糊及高血压,但类固醇激素谱可区分经典型、非经典型与对照组。
要点
- 非经典型11βOHD无外生殖器模糊和高血压,易被临床忽视。
- 经典型诊断年龄更早、骨龄/年龄比更高、成年身高更低。
- 11-脱氧皮质醇/皮质醇比值可区分经典型、非经典型与对照组。
核心结论
- 非经典型11βOHD因临床表现相对轻微而易被临床忽视,但类固醇激素谱可实现11βOHD的诊断、鉴别诊断和分型。
研究设计与样本
- 多中心儿童队列回顾性研究,纳入102例11βOHD患者(经典型92例,非经典型10例),来自76个家庭,其中46,XX患者53例。
主要发现
- 102例患者均携带CYP11B1双等位基因突变,30个突变中9个为新发突变。
- 5例46,XX患者(10%)按男性抚养,19例患者(19%)最初被误诊为21-羟化酶缺陷症。
- 女性成年身高152 cm(-1.85 SDS),男性160.4 cm(-2.56 SDS)。
- 非经典型女孩均无外生殖器模糊(经典型为100%),非经典型患者均无高血压(经典型为50%)。
- 与经典型相比,非经典型诊断年龄更晚(6.9 vs 1.33岁;P < 0.0001),骨龄/年龄比更低(P = 0.04),成年身高更高(-1.32 vs -2.46 SDS;P = 0.05)。
关键数值与推荐
- 11-脱氧皮质醇/皮质醇比值>2.2、<1.5和<0.1分别对区分经典型11βOHD、非经典型11βOHD和对照组具有100%特异性。
临床怎么用
- 对临床疑似11βOHD患者应进行CYP11B1基因测序和类固醇激素谱分析以明确诊断和分型。
- 非经典型11βOHD临床表现轻微,需警惕误诊为21-羟化酶缺陷症,类固醇激素谱有助于鉴别。
局限性
- 回顾性研究设计。
- 非经典型患者样本量较小(n=10)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given the rarity of 11β-hydroxylase deficiency (11βOHD), there is a paucity of data about the differences in clinical and biochemical characteristics of classic (C-11βOHD) and nonclassic 11βOHD (NC-11βOHD). OBJECTIVE: To characterize a multicenter pediatric cohort with 11βOHD. METHOD: The clinical and biochemical characteristics were retrospectively retrieved. CYP11B1 gene sequencing was performed. Seventeen plasma steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. RESULTS: 102 patients (C-11βOHD, n = 92; NC-11βOHD, n = 10) from 76 families (46,XX; n = 53) had biallelic CYP11B1 mutations (novel 9 out of 30). Five 46,XX patients (10%) were raised as males. Nineteen patients (19%) had initially been misdiagnosed with 21-hydroxylase deficiency. Female adult height was 152 cm [-1.85 SD score (SDS)] and male 160.4 cm (-2.56 SDS).None of the NC-11βOHD girls had ambiguous genitalia (C-11βOHD 100%), and none of the NC-11βOHD patients were hypertensive (C-11βOHD 50%). Compared to NC-11βOHD, C-11βOHD patients were diagnosed earlier (1.33 vs 6.9 years; P < 0.0001), had higher bone age-to-chronological age (P = 0.04) and lower adult height (-2.46 vs -1.32 SDS; P = 0.05). The concentrations of 11-oxygenated androgens and 21-deoxycortisol were low in all patients. The baseline ACTH and stimulated cortisol were normal in NC-11βOHD. Baseline cortisol; cortisone; 11-deoxycortisol; 11-deoxycorticosterone and corticosterone concentrations; and 11-deoxycortisol/cortisol, 11-deoxycorticosterone/cortisol, and androstenedione/cortisol ratios were higher in C-11βOHD than NC-11βOHD patients (P < 0.05). The 11-deoxycortisol/cortisol ratio >2.2, <1.5, and <0.1 had 100% specificity to segregate C-11βOHD, NC-11βOHD, and control groups. CONCLUSION: NC-11βOHD can escape from clinical attention due to relatively mild clinical presentation. However, steroid profiles enable the diagnosis, differential diagnosis, and subtyping of 11βOHD.
引用
- Yildiz M, Isik E, Abali ZY, et al. Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2021. PMID: 33830237. doi:10.1210/clinem/dgab225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。